Alabama § 22-5D-3 Availability to Eligible Patient of Investigational Drug, Biological Product, or Device

Alabama Statutes

§ 22-5D-3 — Availability to Eligible Patient of Investigational Drug, Biological Product, or Device

Alabama·Title 22 Health, Mental Health, and Environmental Control·Ch. 5D Gabe Griffin Right to Try Act

(a)The manufacturer of an investigational drug, biological product, or device may make available and an eligible patient may request the manufacturer’s investigational drug, biological product, or device under this chapter. This chapter does not require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient.

(b)A manufacturer may do all of the following:

(1)Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation.

(2)Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.

Free access — add to your briefcase to read the full text and ask questions with AI

(a) The manufacturer of an investigational drug, biological product, or device may make available and an eligible patient may request the manufacturer’s investigational drug, biological product, or device under this chapter. This chapter does not require that a manufacturer make available an investigational drug, biological product, or device to an eligible patient.
(b) A manufacturer may do all of the following:
(1) Provide an investigational drug, biological product, or device to an eligible patient without receiving compensation.
(2) Require an eligible patient to pay the costs of, or the costs associated with, the manufacture of the investigational drug, biological product, or device.

Alabama § 22-5D-3 (Availability to Eligible Patient of Investigational Drug, Biological Product, or Device) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.